Sustainability kudos EcoVadis Silver medal for 2025 sustainability performance highlights a strong sustainability narrative and potential to partner on eco-friendly diagnostic workflows or supply chain transparency initiatives.

Global expansion Operating across six sites in four countries with R&D and manufacturing on three continents suggests ready-made opportunities to cross-sell reagents, enzymes, and automated systems to existing regional facilities and to leverage international shipping capabilities.

Rapid test momentum Recent RSV rapid test launches and a focus on point-of-care immunoassays indicate capacity to expand with complementary rapid diagnostics portfolios and bundled solutions for clinics and hospitals.

Collaborative growth Strategic partnerships, such as the Microbix collaboration and the PEI BioAlliance client relationship, point to an openness to co-development and distribution partnerships that sales teams can exploit for joint go-to-market plays.

Investing in capacity Significant capital investments in cGMP microbial capacity and advanced manufacturing facilities signal readiness for scale and potential upsell of high-throughput reagents and automated systems to increase throughput for customers.